Table 2 Comparative analysis of hospitalization and follow-up outcomes between the two groups.
Variables | HE rates ≥ 70% (n = 43) | HE rates < 70% (n = 47) | Total (n = 90) | P value |
|---|---|---|---|---|
Intubation time, days, median (IQR) | 3 (1–4) | 5 (3–7) | 4 (2–5) | 0.004 |
Residual hematoma volume, mL, median (IQR) | 6.96 (3.52–9.97) | 18.86 (15.74–30.80) | 13.43 (6.63–20.11) | < 0.001 |
mRS score at discharge, n (%) | 0.844 | |||
0–3 | 8 (18.6) | 8 (17.0) | 16 (17.8) | |
4–6 | 35 (81.4) | 39 (83.0) | 74 (82.2) | |
Discharge GCS scores, median (IQR) | 14.5 (11–15) | 13 (7–15) | 13 (10–15) | 0.078 |
mRS score at last follow-up, n (%) a | 0.699 | |||
0–3 | 20 (57.1) | 20 (52.6) | 40 (54.8) | |
4–6 | 15 (42.9) | 18 (47.4) | 33 (45.2) | |
Mortality at last follow-up, n (%) a | 7 (20.0) | 9 (23.7) | 16 (21.9) | 0.704 |
Duration of hospitalization, days, median (IQR) | 17.0 (13.5–27.0) | 17.5 (13.75–27.25) | 18.5 (13.75–27.0) | 0.383 |
Total hospitalization expenses, ￥, median (IQR) | 37,200.17 (21,000.59–67,381.93) | 53,535.32 (32,783.81–72,962.02) | 47,659.78 (24,210.15–69,156.10) | 0.145 |
